Literature DB >> 27170890

Principal Dynamic Mode Analysis of EEG Data for Assisting the Diagnosis of Alzheimer's Disease.

Yue Kang, Javier Escudero, Dae Shin, Emmanuel Ifeachor, Vasilis Marmarelis.   

Abstract

We examine whether modeling of the causal dynamic relationships between frontal and occipital electroencephalogram (EEG) time-series recordings reveal reliable differentiating characteristics of Alzheimer's patients versus control subjects in a manner that may assist clinical diagnosis of Alzheimer's disease (AD). The proposed modeling approach utilizes the concept of principal dynamic modes (PDMs) and their associated nonlinear functions (ANF) and hypothesizes that the ANFs of some PDMs for the AD patients will be distinct from their counterparts in control subjects. To this purpose, global PDMs are extracted from 1-min EEG signals of 17 AD patients and 24 control subjects at rest using Volterra models estimated via Laguerre expansions, whereby the O1 or O2 recording is viewed as the input signal and the F3 or F4 recording as the output signal. Subsequent singular value decomposition of the estimated Volterra kernels yields the global PDMs that represent an efficient basis of functions for the representation of the EEG dynamics in all subjects. The respective ANFs are computed for each subject and characterize the specific dynamics of each subject. For comparison, signal features traditionally used in the analysis of EEG signals in AD are computed as benchmark. The results indicate that the ANFs of two specific PDMs, corresponding to the delta-theta and alpha bands, can delineate the two groups well.

Entities:  

Keywords:  Alzheimer’s disease; EEG signal processing; assistive diagnosis; nonlinear modeling

Year:  2015        PMID: 27170890      PMCID: PMC4848106          DOI: 10.1109/JTEHM.2015.2401005

Source DB:  PubMed          Journal:  IEEE J Transl Eng Health Med        ISSN: 2168-2372            Impact factor:   3.316


  16 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Alzheimer's disease.

Authors:  Kaj Blennow; Mony J de Leon; Henrik Zetterberg
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

3.  Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease.

Authors:  C J Stam; W de Haan; A Daffertshofer; B F Jones; I Manshanden; A M van Cappellen van Walsum; T Montez; J P A Verbunt; J C de Munck; B W van Dijk; H W Berendse; P Scheltens
Journal:  Brain       Date:  2008-10-24       Impact factor: 13.501

Review 4.  Connectivity measures applied to human brain electrophysiological data.

Authors:  R E Greenblatt; M E Pflieger; A E Ossadtchi
Journal:  J Neurosci Methods       Date:  2012-03-16       Impact factor: 2.390

5.  Regional coherence evaluation in mild cognitive impairment and Alzheimer's disease based on adaptively extracted magnetoencephalogram rhythms.

Authors:  Javier Escudero; Saeid Sanei; Delaram Jarchi; Daniel Abásolo; Roberto Hornero
Journal:  Physiol Meas       Date:  2011-06-27       Impact factor: 2.833

6.  A comparative study of synchrony measures for the early diagnosis of Alzheimer's disease based on EEG.

Authors:  J Dauwels; F Vialatte; T Musha; A Cichocki
Journal:  Neuroimage       Date:  2009-06-30       Impact factor: 6.556

7.  Model-based quantification of cerebral hemodynamics as a physiomarker for Alzheimer's disease?

Authors:  V Z Marmarelis; D C Shin; M E Orme; R Zhang
Journal:  Ann Biomed Eng       Date:  2013-06-15       Impact factor: 3.934

Review 8.  EEG dynamics in patients with Alzheimer's disease.

Authors:  Jaeseung Jeong
Journal:  Clin Neurophysiol       Date:  2004-07       Impact factor: 3.708

9.  EEG coherence in Alzheimer's dementia.

Authors:  G Adler; S Brassen; A Jajcevic
Journal:  J Neural Transm (Vienna)       Date:  2003-09       Impact factor: 3.575

10.  Changes in the MEG background activity in patients with positive symptoms of schizophrenia: spectral analysis and impact of age.

Authors:  Javier Escudero; Emmanuel Ifeachor; Alberto Fernández; Juan José López-Ibor; Roberto Hornero
Journal:  Physiol Meas       Date:  2013-01-30       Impact factor: 2.833

View more
  5 in total

1.  Methodology of Recurrent Laguerre-Volterra Network for Modeling Nonlinear Dynamic Systems.

Authors:  Kunling Geng; Vasilis Z Marmarelis
Journal:  IEEE Trans Neural Netw Learn Syst       Date:  2016-06-24       Impact factor: 10.451

2.  Multi-Input, Multi-Output Neuronal Mode Network Approach to Modeling the Encoding Dynamics and Functional Connectivity of Neural Systems.

Authors:  Kunling Geng; Dae C Shin; Dong Song; Robert E Hampson; Samuel A Deadwyler; Theodore W Berger; Vasilis Z Marmarelis
Journal:  Neural Comput       Date:  2019-05-21       Impact factor: 2.026

3.  Detection of Impaired Sympathetic Cerebrovascular Control Using Functional Biomarkers Based on Principal Dynamic Mode Analysis.

Authors:  Saqib Saleem; Yu-Chieh Tzeng; W Bastiaan Kleijn; Paul D Teal
Journal:  Front Physiol       Date:  2017-01-09       Impact factor: 4.566

4.  Characterisation of ictal and interictal states of epilepsy: A system dynamic approach of principal dynamic modes analysis.

Authors:  Zabit Hameed; Saqib Saleem; Jawad Mirza; Muhammad Salman Mustafa
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

5.  Systematic Review on Resting-State EEG for Alzheimer's Disease Diagnosis and Progression Assessment.

Authors:  Raymundo Cassani; Mar Estarellas; Rodrigo San-Martin; Francisco J Fraga; Tiago H Falk
Journal:  Dis Markers       Date:  2018-10-04       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.